| Breast cancer |
Angiopoietin (66), ANXA1 (8), CCL17 (80), CCL2 (110,146), CHI3L1 (145), CRKL (147), CXCL1 (62), CXCL14 (80), CXCL5 (146), ECM1 (114), Hsp90α (13), IGFBP-3 (31), IL-10 (107), IL-1β (42), IL-32 (41), Leptin (61), LGALS3BP (73), LOX (22), LRP6N (149), PAI-1 (67), PGRN (9), PKM2 (4), PSAP (148), S100A14 (146), SRGN (81), TGF-α (39), TGF-β1 (40), TINAGL1 (32)
|
| Colorectal cancer |
Apelin (152), CCL1 (106), CCSP-2 (151), CP (150), EGF (2,72), FGL1 (76), HGF (117), IGF2 (36), LRG1 (150), Meprinα (2), Mindin (153), PON1 (150), Reg IV (1), SCF (11), SERPINA3 (150), SPARC (163), TGF-α (2,3), TGF-β2 (105), TIMP1 (150)
|
| Esophageal cancer |
CXCL1 (38), IGF2 (121,122), PAI-1 (102), SPARC (163), TGF-β1 (101)
|
| Gastric cancer |
CCL2 (85), CXCL1 (64), HGF (77), HOP (162), IL-6 (77), IL-8 (44), MMP-9 (50), SPARC (163), TGF-β1 (77)
|
| Glioma |
CCN2 (86), EGFL7 (19), Galectin-8 (24), GPI (25), IL-6 (115), OPN (65)
|
| Hepatocellular carcinoma |
AFP (154-156), AKR1B10 (157), CCL2 (37), CCL5 (37), CCL7 (37), COMP (58), CXCL16 (37), HGF (57), HPCAL1 (160), LCN2 (159), OPN (88), SCF (69), STC1 (158), TGF-β (59), TIMP-1 (59)
|
| Lung cancer |
DKK1 (141), FGL1 (76), FSTL1 (33), IGF2 (10), IL-6 (99), KPNA2 (142), OPN (33), PD-L1 splice variants (132), PGRMC1 (144), PKM2 (17), SCUBE3 (18), SRGN (23), SFRP1 (28), Glycodelin (143)
|
| Melanoma |
FGL1 (76), GM-CSF (74), IL-6 (74), IL-8 (63), TGF-β (74), VEGF (74)
|
| Myeloma |
IL-6 (84,100), MIP-1α (93), Resistin (111), SHH (96)
|
| Oral cancer |
CCN2 (29), MFAP5 (35), Midkine (103)
|
| Osteosarcoma |
AR (92), bFGF (91), CCN2 (87), IL-6 (45)
|
| Ovarian cancer |
ANGII (21), Autotaxin (12), IL-6 (83), IL-8 (5), LPA (12), MGP (89), MSMP (120), PAI-1 (68), Resistin (60), TGF-α (79), TNF-α (79)
|
| Pancreatic cancer |
14-3-3ζ (108), FN (112), HGF (56), IL-1β (26), IL-6 (54), OPN (53), SDF-1 (55) CA19-9 (161), GM-CSF (43), LIF (52), TGM2 (70,113), THBS2 (161)
|
| Prostate cancer |
CCL2 (16), HMGB1 (78), IL-1β (71), IL-6 (78), MIC-1 (90), TNF-α (15)
|
